�����������

Application Deadline (for all): Feb. 26, 2025
Award: Designed to support research that improves the quality of life for patients with Waldenstrom’s macroglobulinemia (a rare, slow-growing type of blood cancer that affects the white blood cells). The program funds innovative research projects in various key areas of WM research, including genomics, epigenomics, signaling pathways, immunology, and the tumor microenvironment

1. IWMF-LLS Strategic Research Roadmap Initiative
   Amount: $200,000 for two year project
2. Robert A. Kyle Career Development Award Program
   Amount: $75,000 each year for a two year project.
3. IWMF Research Seed Money Initiative
   Amount: $75,000 each year for a one year project.
4. IWMF-LLS Enhanced Research Roadmap Initiative
   Amount: Up to $1.5 million per grant, including indirect costs. 2-4 year project.
5. IWMF-LLS Companion Initiative
   Amount: Up to $100,000 per grant, with a total award of $120,000 including indirect costs. 1-2 year project

Contact: Please contact Tiffany Garnder, Associate Director of Foundation Relations at tiffany.gardner@bcm.edu for additional information.

The Ben & Catherine Ivy Foundation
Application Deadline: March 1, 2025
Budget: $600,000 over 2 years
Provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma.  This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.

Contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu with any questions.

The Ben & Catherine Ivy Foundation
Application Deadline: March 1, 2025
Budget: $500,000 over 2 years
Provides support to early-to-mid-career investigators conducting high-impact, high-reward translational research for glioblastoma. This award is intended to support ambitious pilot projects designed to identify drug strategies appropriate for early-phase pharmacodynamic- and pharmacokinetic-driven clinical trials.

Contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu with any questions.

Pediatric Cancer Research Foundation
LOI Deadline: March 1, 2025
Budget: $450,000 over 3 years 
These grants fund basic science, translational and/or clinical pediatric cancer research initiatives. These grants fund work that is the basis for childhood cancer research, helping to move science in the direction of improved treatments and eventually finding a cure. They are designed to move hypothesis-driven research into the clinic providing support for important preclinical projects that are necessary to move a study from the pre-clinical arena into a clinical trial. Applicants must be a PhD (with a least two years as a junior faculty or assistant professor) and/or MD. 

*Limited Institutional Submission Opportunity requiring an LOI and internal selection led by the Pediatric department.

Contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu with any questions.

Pediatric Cancer Research Foundation
LOI Deadline: March 1, 2025
Budget: $200,000 over 2 years 
These grants fund new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with highrisk cancers. This grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. Applicants must be a PhD and/or MD. 

*Limited Institutional Submission Opportunity requiring an LOI and internal selection led by the Pediatric department.

Contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu with any questions.

Pediatric Cancer Research Foundation
LOI Deadline: March 1, 2025
Budget: $60,000 over 1 year 
These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. 

*Limited Institutional Submission Opportunity requiring an LOI and internal selection led by the Pediatric department.

Contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu with any questions.

To encourage a commitment to breast cancer research and help advance the careers of young researchers who do not yet have their own major grant support, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including post docs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant. This grant is open to applicants at institutions throughout the contiguous United States. This is a two-year grant for a total of $125,000, with half the grant award being paid out each year.

Please look carefully at the awards to see where you fit. The DLDCCC can submit a maximum of only two names across both grant types.

If you are interested, please upload your current NIH biosketch and a one-page LOI including hypothesis, research aim(s), brief discussion of the project’s potential impact and methods as a single PDF file via the DLDCCC Proposal/LOI Submission Form by Sunday, March. 2, 2025. This will be reviewed by the DLDCCC-appointed panel. If chosen, you will have until March 31 to submit the final LOI to BCA.

• Format Requirement: Please name your pdf file as follows:
  NAME OF SPONSOR_PI LAST NAME_LOI
  Example: CPRIT_SMITH_LOI

For questions regarding the grant opportunity, please contact Lyndsie Whitehead, Assistant Director of Foundation Relations, at lyndsie.whitehead@bcm.edu.

For inquiries related to submission, please contact DLDCCCgrants@bcm.edu. Thank you.

Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including post-docs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant. This award recognizes creative, unique and innovative research and is open to applicants at institutions throughout the contiguous United States. This is a one year grant for a total of $100,000.

Please look carefully at the awards to see where you fit. The DLDCCC can submit a maximum of only two names across both grant types.

If you are interested, please upload your current NIH biosketch and a one-page LOI including hypothesis, research aim(s), brief discussion of the project’s potential impact and methods as a single PDF file via the DLDCCC Proposal/LOI Submission Form by Sunday, March. 2, 2025. This will be reviewed by the DLDCCC-appointed panel. If chosen, you will have until March 31 to submit the final LOI to BCA.

• Format Requirement: Please name your pdf file as follows:
  NAME OF SPONSOR_PI LAST NAME_LOI
  Example: CPRIT_SMITH_LOI

For questions regarding the grant opportunity, please contact Lyndsie Whitehead, Assistant Director of Foundation Relations, at lyndsie.whitehead@bcm.edu.

For inquiries related to submission, please contact DLDCCCgrants@bcm.edu. Thank you.

Application Deadline: March 3, 2025
Budget: Stipend of $74,000 for the first year, $76,000 for the second year, and $78,000 for the third year.
Award: CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology. The applicant should make every effort to demonstrate the potential of the proposed studies to directly impact the foundatio’s understanding of the immune system’s role in cancer.

Contact Andrea Calo, Assistant Vice President, Foundation Relations and Strategic Partnership at macalo@bcm.edu with questions.

Application Deadline: March 3, 2025
Budget: Stipend of $74,000 for the first year, $76,000 for the second year, and $78,000 for the third year
Award: There is a burgeoning need in cancer immunology for scientists with expertise and understanding in both quantitative and biological sciences. The fellowships will support both computational biologists who seek to strengthen their knowledge of immunology and cancer immunologists who seek training in computational biology, data science, and/or genomics under the mentorship of world-renowned scientists in these disciplines.

Contact Andrea Calo, Assistant Vice President, Foundation Relations and Strategic Partnership at macalo@bcm.edu with questions.

Award Name:
Application Deadline: March 3, 2025
Amount (including indirect costs): $50,000 over 1 year

Brief Description of Mechanism: This award is presented to a clinical doctor or research scientist whose primary focus is brain cancer research. Clinical projects are encouraged, as well as translational projects with significant clinical promise. Projects for adult and pediatric brain cancer research will be considered.

Contact Alex Hood, Associate Director Foundation Relations at alex.hood@bcm.edu with any questions.

*Limited Institutional Submission Opportunity requiring LOI and Internal Selection

The Dan L Duncan Comprehensive Cancer Center (DLDCCC) has been invited to participate in the 2025 V Foundation Adult Translational Cancer Research funding opportunity. This RFA is restricted to adult cancer research in the preclinical or translational space with a focus on bench-to-bedside strategies. This funding opportunity has two grant mechanisms:

• : Open to faculty conducting translational research in adult cancer. The project must have clinical relevance within three years of the grant’s conclusion. Funding includes a four-year award of $800,000, paid in $200,000 annual installments.
• : Open only to prior V Foundation grantees who have completed or are in the final year of a prior V Foundation research grant. It supports high-risk, high-reward, transformative projects with a significant impact on cancer treatment and understanding. Funding includes a five-year award of $1,000,000, paid in $200,000 annual installments.

DLDCCC can submit only one nominee per category, so applicants are encouraged to carefully review the eligibility criteria in the attached RFAs and before applying.

If interested, please upload a one-page letter of intent(LOI) for the project and current NIH biosketch to the DLDCCC Proposal/LOI Submission Form by Tuesday, March. 4, 2025. The LOI will be reviewed by the DLDCCC-appointed panel to make the final decision on nominations. Nomination due to foundation is March 18, 2025 (4:00 PM CT). If chosen, you will have until April 16 (4:00 PM CT) to submit the full application to the foundation.

Format Requirement: Ensuring all materials are uploaded as a single PDF file.
Please name your LOI file as follows:
NAME OF SPONSOR_PI LAST NAME_LOI
Example: CPRIT_SMITH_LOI

For questions, please contact the DLDCCC grants team at DLDCCCgrants@bcm.edu.

Prostate Cancer Foundation -

Deadline: Monday, March 10, 2025, 3 p.m., Eastern Daylight Time (EDT)
Award: PCF invites proposals addressing disparities in care experienced by patients with prostate cancer which may focus on implementation research in various populations (e.g., urban vs rural, racial, geographic or financial) or in drivers of care and outcome disparities that could potentially be addressed through changes in policy, advocacy or education. Applicants are encouraged to solicit and integrate advice from patients, patient support groups or advocates.

Budget: $75,000 per year for 3 years ($225k total) – indirect costs not allowed

Contact: Please contact Mary Hall Nunciato, Senior Director of Foundation Relations with any questions.

Sontag Foundation -

Budget: $750,000 over five years ($150k/year)
Deadline: March 12, 2025, by 11:59 p.m. ET
Award: The Foundation is currently soliciting applications for its Distinguished Scientist Award. The goal of this funding initiative is to change the paradigm of brain cancer research by building a community of outstanding scientists whose pioneering approaches have the potential to make significant advances in the field of brain cancer/brain tumors. The Foundation believes that multi-disciplinary collaborations are critical to advancing research. Researchers from various scientific backgrounds are strongly encouraged to apply.

Contact: Please contact Mary Hall Nunciato, Senior Director of Foundation Relations with any questions.

-
LOI Deadline: March 12, 2025
Amount: $25,000 – $250,000 for one- to two-year projects 
Award: Funds interdisciplinary and translational research efforts that will lead to rapid discovery and development of therapies or strategies that treat, control, or cure Fanconi anemia (FA). Must hold a PhD, MD, or equivalent degree. Early stage investigators encouraged to apply.

Please contact Alex Hood, Associate Director Foundation Relations at alex.hood@bcm.edu with any questions.

Application Deadline: March 13, 2025
Amount: $200,000 over 3 years
Provides research funding to clinical investigators, who have received their initial faculty appointment, as they work to establish an independent clinical cancer research program. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. The research must have a patient-oriented focus, including a clinical research study and/or translational research involving human subjects. Applications in all areas of cancer research are accepted from U.S. and international applicants. Must be in the first to fourth year of a full-time primary faculty appointment at the time of grant submission. Applicants may not concurrently hold other career development awards from private foundations during the CDA-supported project term.

Contact Alex Hood, Associate Director Foundation Relations, at alex.hood@bcm.edu with any questions.

-
Application Deadline: March 14, 2025
Amount: Up to $200,000 over 2 years plus 12% indirect 
Award: Provides grants to support and test novel bioinformatics applications in cancer aimed at clinical impact. Applications must be submitted by a team that includes at least one cancer researcher and one bioinformatics researcher.

Please contact Alex Hood, Associate Director Foundation Relations at alex.hood@bcm.edu with any questions.

with the Diana Helis Henry Medical Research Foundation (DHHMRF) and Adrienne Helis Malvin Medical Research Foundation (AHMMRF)

Amount: Up to $675,000 Total for 3 years

BCM is soliciting proposals to conduct cancer-related research in collaboration with the Dianna Helis Henry Medical Research Foundation and Adrienne Helis Malvin Medical Research Foundation (HMRFs). The primary goal of this opportunity is to foster fundamental, discovery driven biomedical research that may lead to target validation, new target identification and/or drug development. Whereas projects may contain a drug development aim, they should not focus solely on drug development. Projects dealing primarily with epidemiology or frank clinical trials will not be considered. The HMRFs also will not consider proposals that are merely supplements or extensions of on-going research funded by other agencies. HMRFs encourage novel areas of research and risk taking, and value the premise of the hypothesis/idea of the project as much as the extent of preliminary data.

Due Friday, March 14, 2025

For those interested in applying please see attached and with submission details.

LOI Deadline: March 17, 2025

Full Application Deadline: June 1, 2025

Budget: $250,000 total direct costs for a 2-year award; no indirect costs are allowed

Award: This Request for Applications (RFA) is a call for investigators to propose ways to implement, utilize, and/or study the impact of technology to advance the conduct of cancer clinical trials. Projects must include the use of Clinical PipeTM to transfer study data for one or more trials (sponsored or investigator-initiated); this grant will not support the trials themselves. Special consideration will be given to multi-institutional projects/studies at sites that do not currently have the EHR-to-EDC connector Flatiron Clinical PipeTM installed.

Contact: Please contact Lyndsie Whitehead, Assistant Director of Foundation Relations, at lyndsie.whitehead@bcm.edu for additional information.

LOI Deadline: March 17, 2025

Full Application Deadline: June 1, 2025

Budget: $4.07M ($3.7M direct costs plus 10% indirect costs) for a 4-year project period

The PI may propose any combination of subawards and core costs as long as they do not exceed specified budget limits. Research subawards include the following ACS research grant mechanisms:

• Clinician Scientist Development Grants (CSDGs) - $135,000 direct costs per year (three to four years)
• Research Scholar Grants (RSGs) - $215,000 per year direct costs per year (four years)
  Award: Successful applications will propose well-designed research projects poised to make an impact on their local community within the framework of a coordinated center approach that’s focused on demonstrated health inequities. Projects may span the cancer continuum and include health promotion, cancer prevention, screening, treatment, access to care, care delivery, and/or survivorship.

Please contact Lyndsie Whitehead, Assistant Director of Foundation Relations, at lyndsie.whitehead@bcm.edu for additional information.

The Dan L Duncan Comprehensive Cancer Center is seeking to fund 1 to 2 one-year pilot projects up to $50,000 each to catalyze collaborations at BCM to better understand the role of the environment in cancer etiology, response to therapy, and survivorship.

Focus Area: Cancer and the Environment

Particularly interested :

• Projects focused on cancers that have been identified as catchment area priorities - please see COE section of DLDCCC website for more information
• Collaborative projects between DLDCCC members
  • All cancer center members who have a faculty appointment are eligible to apply.
  • Indirect costs are not allowed
  • No BRAIN submission required.

How to Apply

Review the full descriptions in the , as well as the provided

Upload all the application requirements as a single PDF file to the DLDCCC Proposal Submission Portal by March 25, 2025.

For questions about this RFA, contact to “Julia” Juhee Hong (Juhee.hong@bcm.edu) or Chris Horaist (chris.horaist@bcm.edu).

The Dan L Duncan Comprehensive Cancer Center is seeking three (3) one-year pilot projects up to $50,000 each.

Focus Area: Immunotoxicity in Cancer

The DLDCCC is interested in providing pilot support to innovative translational research projects that may evolve into full grants or SPORE projects, or that may secure other peer-reviewed funding. The projects must focus on toxicities of immune therapies (e.g., cell therapy transplant or checkpoint inhibition) and/or pathologic inflammation associated with cancer. With this RFA, we are also expanding the application to include fundamental immunology that may be relevant to broader immune pathology mechanisms.

• All cancer center members who have a faculty appointment are eligible to apply.
• Indirect costs are not allowed
• No BRAIN submission required.

How to Apply

Review the full descriptions in the for detailed instructions.

Upload all the application requirements as a single PDF file to the DLDCCC Proposal Submission Portal by March 31, 2025.

For questions about this RFA, contact Carl Allen ceallen@txch.org. 

Deadline: April 2, 2025
Amount: up to $100,000 for one year

Please refer to the attached for detailed information.

To apply, please upload all the application requirements as a single PDF file to:
DLDCCC Proposal Submission Form. 

If you have any questions, please contact DLDCCCgrants@bcm.edu.

Deadline: April 10, 2025, by 8 p.m. ET

Budget: $250,000 over two years ($125k/year) – indirect costs are not allowed

Award: Significant barriers exist that impede the translation of innovative and important ideas to the clinic. The Reach Grant seeks to remove one of these barriers by providing support for important pre-clinical hypothesis-driven research projects that are necessary to move a study from the preclinical arena into a clinical trial. Thus, the goal of this award is to support translational studies that will result in a phase I and/or II clinical trial, two to three years from the project end date. Examples of appropriate research projects include but aren’t limited to, completing IND-enabling studies, providing requisite pre-clinical data for clinical trial development, or validating biomarkers that will enable patient selection for new clinical trials. Proposals must fall within the scope of Alex’s Lemonade Stand Foundation’s mission, focused on childhood cancers. Proposals with a sole/primary focus on patients >19 years of age will not be considered

Contact: Please contact Mary Nunciato, Senior Director of Foundation Relations, at mary.hall@bcm.edu for additional information.

The Dan L Duncan Comprehensive Cancer Center is releasing the first round of Bench to Preclinical Validation (BTPV) RFA for Spring 2025, to be awarded no later than July 2025. The deadline for the BTPV is May 1st, 2025.

How to Apply

Please refer to the for detailed information.

Upload all the application requirements as a single PDF file to the DLDCCC Proposal Submission Portal by May 1, 2025

For questions about this RFA, please contact DLDCCCgrants@bcm.edu. Thank you.

Application Deadline: Ongoing until funds are used.
Budget: $20,000-$40,000, for one year.
Award: The Colon Cancer Coalition seeks to provide funds, to liked-minded partners advancing colon cancer research. Funds must be used on programs that will benefit individuals in and around the event city where the money is raised. Priority will be given to programs working to increase screening for adults over 50 to reach the national goal of 80%, patient screening navigation, or addressing young adult onset colorectal cancer.

Contact: Please contact Lyndsie Whitehead, Assistant Director of Foundation Relations at lyndsie.whitehead@bcm.edu for additional information.